|
Real-time Estimate
Cboe BZX
22:46:20 29/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 12.86 USD | -1.38% |
|
-6.92% | +0.08% |
| 10-20 | Freenome, Inc. Launches SimpleScreenTM Lung And Personalized Cancer Detection Offering With SimpleScreen CRC | CI |
| 10-20 | Freenome Launches SimpleScreen Lung Cancer Test | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.44B | - | - | - | - | - |
| 64.14B | |||||
| 55.53B | |||||
| 53.03B | |||||
| 45.99B | |||||
| 42.45B |
- Stock Market
- Stocks
- FRNM Stock
- Charts Freenome, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
